Skip Navigation


Annals of Oncology Advance Access originally published online on November 1, 2005
Annals of Oncology 2006 17(4):720-721; doi:10.1093/annonc/mdj056
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/4/720    most recent
mdj056v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by De Vita, S.
Right arrow Articles by Sica, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Vita, S.
Right arrow Articles by Sica, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

letter to the editor

Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM

The first 10% of the full text of this article appears below.

Imatinib is an inhibitor of tyrosine kinase currently employed for the treatment of chronic myelogenous leukemia and inoperable gastrointestinal stromal tumor (GIST).

Several trials [1Go, 2Go] have been conducted recently with imatinib as monotherapy for treatment of glioblastoma multiforme (GBM) and preliminar results suggest a good level of efficacy in this . . . [Full Text of this Article]

S. De Vita*, S. De Matteis, L. Laurenti, P. Chiusolo, F. Sorà, N. Piccirillo, G. Reddiconto, A. Fiorini, G. Leone and S. Sica

Department of Hematology, Universita' Cattolica del Sacro Cuore, Largo Gemelli 8, 00168 Rome, Italy

* (E-mail: emacat@rm.unicatt.it)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?